P2‐083: Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease with low‐dose pioglitazone. (1st July 2015) - Budur, Kumar; Welsh-Bohmer, Kathleen; Burns, Daniel K.; Chiang, Carl; O'Neil, Janet; Runyan, Grant; Culp, Meredith; Crenshaw, Donna G.; Lutz, Michael W.; Metz, Craig A.; Saunders, Ann M.; Yarbrough, Deborah; et al.